Association of use of high-dose cyproterone acetate and risk of meningioma in women

Dr. Alain Weill

An observational chort study in France found a strong dose-effect relation between use of cyproterone acetate and risk of intracranial meningioma in women (exposed versus unexposed 23.8 versus 4.5 per 100.000 person years).